Skip to main content
Timothy Kuzel, MD, Oncology, Orland Park, IL

Timothy Kuzel MD FACP

Oncology•Orland Park, IL

Cutaneous Lymphoma, Genitourinary Oncology, Hematologic Oncology, Melanoma

Clinical Professor of Medicine Northwestern University Distinguished Physician, St George corp Associate Director Clinical Research Network, Robert H Lurie Comprehensive Cancer Center Northwestern University Oncology Service Line Lead, South Region

Join to view full profile

  • 15300 West AveRobert H Lurie Comp Ca CtrOrland Park, IL 60462

  • Phone+1 708-226-2513

  • Fax+1 312-942-3192

Dr. Kuzel is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Kuzel's full profileAlready have an account?

Summary

  • Dr. Timothy Kuzel is an oncology specialist based in Orland Park, IL, with subspecialties in cutaneous lymphoma, genitourinary oncology, hematologic oncology, and melanoma. He completed his fellowship in hematology and medical oncology at McGaw Medical Center of Northwestern University in 1990. Dr. Kuzel serves as a clinical professor of medicine at Northwestern Medicine and has been affiliated with Rush University Medical School since 2016. His research experience includes amyloidosis, hematologic oncology, seminoma, yolk sac tumor, and choriocarcinoma, with several publications in reputable journals. He has been involved in clinical trials focusing on various forms of melanoma and cutaneous T-cell lymphoma. He has been recognized multiple times in Chicago Magazine's Top Doctors list and as one of America's Top Doctors by Castle Connolly.

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1987 - 1990
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1984 - 1987
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1984
  • University of Michigan
    University of MichiganBA, Biomedical Sciences, Cum Laude, 1978 - 1981
  • University of Michigan
    University of MichiganB.S., Biomedical Sciences, 1981

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1985 - 2029
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Chicago Magazine: Top Doctors Castle Connolly, 2008, 2010, 2012, 2014, 2016, 2018, 2020
  • America's Top Doctors Castle Connolly, 2008-2017
  • America's Top Doctors for Cancer Castle Connolly, 2007-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Type 2 Innate Lymphoid Cells Impede IL-33–Mediated Tumor Suppression  
    Timothy M Kuzel, Bin Zhang, The Journal of Immunology
  • The Present and Future Cardiovascular Medicine and Society the Cardiologist and the Cancer Patient: Challenges to Cardio-Oncology (Or Onco-Cardiology) and Call to Action  
    Agne Paner, Hena Patel, Timothy Kuzel, Parameswaran Venugopal, Tochi M Okwuosa, Nicole Prabhu, Kim A Williams, ScienceDirect
  • The efficacy of lenvatanib and everolimus in Chromophobe-type non-Clear Cell Renal Cell Cancer: A case report and Literature review  
    Schwartz C, Pfanzelter N, Kuzel TM, Clin Genitourin Cancer, 1/25/2017

Books/Book Chapters

  • Hematology: Basic Principles and Practice 
    Chapter: T-cell Lymphomas. Chapter 85 
    Page 1343 - 1380O'Connor OA, Bhagat G, Ganapathi KA, Kaplan J, Corradini P, Guitart J, Rosen ST and Kuzel TMEditors: Hoffman R, Benz EJ, Silberstein LE, Heslop H, Weitz JI, and Anastasi J.Elsevier/Saunders, Philadelphia, PAEdition 7th,2018
  • Cancer Consult: Expertise for Clinical Practice 
    Chapter: Management of Renal Cell Carcinoma. Chapter 95 
    MacVicar, Gary and Kuzel TMEditors: Markman M and Abutalib S.Wiley, Oxford, United Kingdom2014
  • Cancer Consult: Expertise for Clinical Practice 
    Chapter: Management of Bladder Cancer. Chapter 96 
    MacVicar, Gary and Kuzel TMEditors: Markman M and Abutalib S.Wiley, Oxford, United Kingdom2014

Abstracts/Posters

  • A Phase 1a/1b Trial of ST-001, a Fenretinide Phospholipid Suspension for 4-Hour Intravenous Infusion in Relapsed/Refractory T-Cell Non-HodgkinÍs Lymphoma
    Timothy M. Kuzel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Impact of use of Phosphodiesterase Type 5 Inhibitors (PDE5-I) after Radical Prostatectomy (RP) on Biochemical Recurrence-free (BCRF) and Overall Survival (OS): A Retro...
    Arden B. Roston, Irene B. Helenowski, William Catalona, Robin Leikin, Michael Gurley, Luke Trapp, Borko Jovanovic, Timothy M. Kuzel, J Clin Oncol; Proc of GU ASCO, 1/1/2017
  • Analysis of overall survival (OS) based on tumor target lesion change in the phase 3 METEOR trial of cabozantinib (cabo) versus everolimus (eve) in advanced renal cell...
    Sumanta Pal, Robert J Motzer, Mayer Fishman, Raymond McDermott, Jose Passos Coelho, Evgeniy Kopyltsov, Xavier Garcia del Muro Solans, Jesús Garcia Donas, Ramazan Yildi..., J Clin Oncol; Proc of GU ASCO, 1/1/2017

Lectures

  • Updated Analyses of the International, Open-label, Randomized, Phase 3 ALCANZA Study: Longer-term Evidence for Superiority of Brentuximab Vedotin Versus Methotrexate o... 
    London, United Kingdom - 1/13/2017
  • Immunotherapy of Cancer 
    1/1/2012
  • A phase 2 mutli-center, randomized, open-label study of two dose levels of IMO-2055 in Patients with metastatic or recurrent Renal Cell Carcinoma. 
    1/1/2009

Other

  • The use of Gemcitabine in metastatic urothelial transitional cell cancer 
    Kuzel TM and Stadler WM, Lilly Monograph
    1/1/1996
  • Book Review of --Atkins MB and Mier JW. Therapeutic Applications of Interleukin-2. 
    Kuzel TM, Doody's Health Sciences Book Review Annual
    1/1/1993
  • Interferons: Basic Principles and Clinical Applications. 
    Kuzel TM. Book Review of --Estrov Z, Kurzock R, and Talpaz M, Doody's Health Sciences Book Review Annual
    1/1/1993

Press Mentions

  • Investigating New Treatments for Rare Skin Lymphomas
    Investigating New Treatments for Rare Skin LymphomasJanuary 17th, 2025
  • Combination Treatment Improves Survival in Advanced Prostate Cancer with Genetic Mutations
    Combination Treatment Improves Survival in Advanced Prostate Cancer with Genetic MutationsSeptember 6th, 2024
  • Rush Earns ASCO QOPI Certification for High-Quality Cancer Care
    Rush Earns ASCO QOPI Certification for High-Quality Cancer CareSeptember 5th, 2019

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Timothy Kuzel, Dr. Timothy Kuzel, MD, Dr. T Kuzel